Atherosclerosis is a life-long illness that begins with risk factors, which in turn contribute to
the development of subclinical disease, followed by the establishment of overt …

Echocardiography is one of the most commonly performed noninvasive diagnostic tests in
patients with known or suspected cardiovascular diseases. Echocardiography provides …

The development of atherosclerotic vascular disease is invariably linked to the formation of
bioactive lipid mediators and accompanying vascular inflammation. Lipoprotein-associated …

Abstract Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary
complications such as acute myocardial injury, renal failure or thromboembolic events. A …

Prolonged or excessive exposure to oxidized phospholipids (OxPLs) generates chronic
inflammation. OxPLs are present in atherosclerotic lesions and can be detected in plasma …

Several emerging plasma biomarkers may ultimately prove useful in risk stratification and
prognosis of cardiovascular disease. The clinical utility of these biomarkers will depend on …

Background Elevated lipoprotein (a) and familial hypercholesterolaemia are both
independent risk conditions for cardiovascular disease. Although signs of atherosclerosis …

Acute coronary syndromes (ACS) are frequently reported in patients with coronavirus
disease 2019 (COVID‐19) and may impact patient clinical course and mortality. Although …

Background—Oxidized phospholipids (OxPL) are present within atherosclerotic plaques
and bound by lipoprotein (a)[Lp (a)] in plasma. This study evaluated the impact of …

Objectives: This study was designed to determine whether simvastatin improves endothelial
function in children with familial hypercholesterolemia (FH). Background: Endothelial …